Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
NRG-GU009: Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation PREDICT-RT
A Phase II Multiple-Dose, Multiple-Arm, Parallel Assignment Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of XmAb20717 Alone or in Combination with Chemotherapy or Targeted Therapies in Selected Subjects with Metastatic Castration-Resistant Prostate Cancer
A Phase III, Multi-center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA IT PET/CT in Men with Biochemical Recurrence of Prostate Cancer
High-dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer Patients
Study Type: Treatment
Phase: III
NCTID: NCT05838716
Principal Investigator:
Elizabeth Wulff-Burchfield
A Phase I and Randomized Phase II Trial of Radium-223 Dichloride, M3814, Avelumab in Advanced Metastatic Castrate-Resistant Prostate Cancer mCRPC
Pilot of Osanetant to Reduce Testosterone in Men with Adenocarcinoma of the Prostate PORT-MAP
Study Type: Treatment
Phase: Feasibility/Pilot
NCTID: NCT05607342
Principal Investigator:
William Parker
A Phase I Dose Escalation and Expanded Cohort Study of Pf-06821497 in the Treatment of Adult Patients with Relapsed/Refractory Small Cell Lung Cancer SCLC, Castration Resistant Prostate Cancer CRPC and Follicular Lymphoma FL
HoLEP prior to Radiation Therapy for Patients with LUTS/Retention and Concurrent Prostate Cancer
Study Type: Supportive Care
Phase: N/A
NCTID: NCT03802851
Principal Investigator:
Bristol Whiles
Measuring Surgical Recovery After Radical Cystectomy
Effectiveness of the SpaceOAR Vue System in Subjects with Prostate Cancer being Treated with Stereotactic Body Radiotherapy SABRE
Study Type: Prevention
Phase: N/A
NCTID: NCT04905069
Principal Investigator:
Ronald Chen